X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2019 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare, Analyse Abbott India with MYLAN INC. - US - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ABBOTT INDIA vs MYLAN (US) - Comparison Results

ABBOTT INDIA    Change

Formerly known as Knoll Pharmaceuticals Limited, Abbott India Limited (AIL) is a subsidiary of Abbott Capital India Limited in which the latter holds about 69% stake. It is involved in the discovery, development, manufacture and marketing of pharmace... More

MYLAN (US)
   Change

Mylan is one of the world’s leading generics and specialty pharmaceutical company. Its products span to customers in about 140 countries across the world. The company maintains one of the industry’s broadest and highest quality product portfolios, wh... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 ABBOTT INDIA   MYLAN
EQUITY SHARE DATA
    ABBOTT INDIA
Mar-18
MYLAN
Dec-14
ABBOTT INDIA/
MYLAN
5-Yr Chart
Click to enlarge
High Rs6,1104,142-   
Low Rs3,9962,919-   
Sales per share (Unadj.) Rs1,552.21,417.8-  
Earnings per share (Unadj.) Rs188.8170.8-  
Cash flow per share (Unadj.) Rs196.4274.9-  
Dividends per share (Unadj.) Rs55.000-  
Dividend yield (eoy) %1.10-  
Book value per share (Unadj.) Rs796.6704.8-  
Shares outstanding (eoy) m21.25378.37-   
Bonus/Rights/Conversions -OI-  
Price / Sales ratio x3.32.5 130.7%   
Avg P/E ratio x26.820.7 129.5%  
P/CF ratio (eoy) x25.712.8 200.4%  
Price / Book Value ratio x6.35.0 126.6%  
Dividend payout %29.10-   
Avg Mkt Cap Rs m107,3761,335,681 8.0%   
No. of employees `0003.325.0 13.3%   
Total wages/salary Rs m3,9370-   
Avg. sales/employee Rs Th9,929.321,458.5 46.3%   
Avg. wages/employee Rs Th1,185.10-   
Avg. net profit/employee Rs Th1,207.72,585.0 46.7%   
INCOME DATA
Net Sales Rs m32,985536,463 6.1%  
Other income Rs m1,170-3,127 -37.4%   
Total revenues Rs m34,155533,336 6.4%   
Gross profit Rs m5,245133,421 3.9%  
Depreciation Rs m16239,401 0.4%   
Interest Rs m3823,140 0.2%   
Profit before tax Rs m6,21567,753 9.2%   
Minority Interest Rs m0-278 0.0%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m2,2032,849 77.3%   
Profit after tax Rs m4,01264,626 6.2%  
Gross profit margin %15.924.9 63.9%  
Effective tax rate %35.44.2 842.8%   
Net profit margin %12.212.0 101.0%  
BALANCE SHEET DATA
Current assets Rs m22,655471,622 4.8%   
Current liabilities Rs m6,681368,714 1.8%   
Net working cap to sales %48.419.2 252.5%  
Current ratio x3.41.3 265.1%  
Inventory Days Days6578 83.0%  
Debtors Days Days29107 27.2%  
Net fixed assets Rs m835124,109 0.7%   
Share capital Rs m21318,971 1.1%   
"Free" reserves Rs m16,7150-   
Net worth Rs m16,928266,675 6.3%   
Long term debt Rs m0398,386 0.0%   
Total assets Rs m24,1621,074,142 2.2%  
Interest coverage x163.73.9 4,167.4%   
Debt to equity ratio x01.5 0.0%  
Sales to assets ratio x1.40.5 273.3%   
Return on assets %16.88.2 205.2%  
Return on equity %23.724.2 97.8%  
Return on capital %36.913.6 271.1%  
Exports to sales %00-   
Imports to sales %00-   
Net fx Rs m-3,4380-   
CASH FLOW
From Operations Rs m1,52770,518 2.2%  
From Investments Rs m-2,148-55,613 3.9%  
From Financial Activity Rs m-1,024-18,582 5.5%  
Net Cashflow Rs m-1,646-3,676 44.8%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for MYLAN (US) is United States Dollars. All data has been converted at 69.49 Rs / USD

Compare ABBOTT INDIA With: ADCOCK INGRAM (S. Africa)  ACTAVIS (US)  TEVA PHARMA (Israel)  

Compare ABBOTT INDIA With: SANOFI INDIA  DISHMAN PHARMA  ALEMBIC LTD  FULFORD INDIA  NATCO PHARMA  



Today's Market

Modi's Victory Creates Sensex History; Ache Din Ahead?(Podcast)

Throughout the week, one slogan that took over the market and country as a whole was, Ab ki baar phir Modi Sarkar.

Related Views On News

ABBOTT INDIA Announces Quarterly Results (3QFY19); Net Profit Up 1.4% (Quarterly Result Update)

Feb 12, 2019 | Updated on Feb 12, 2019

For the quarter ended December 2018, ABBOTT INDIA has posted a net profit of Rs 1 bn (up 1.4% YoY). Sales on the other hand came in at Rs 9 bn (up 7.5% YoY). Read on for a complete analysis of ABBOTT INDIA's quarterly results.

ABBOTT INDIA Announces Quarterly Results (2QFY19); Net Profit Up 0.1% (Quarterly Result Update)

Nov 14, 2018 | Updated on Nov 14, 2018

For the quarter ended September 2018, ABBOTT INDIA has posted a net profit of Rs 1 bn (up 0.1% YoY). Sales on the other hand came in at Rs 10 bn (up 5.2% YoY). Read on for a complete analysis of ABBOTT INDIA's quarterly results.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

The Power of 5 Minutes (The 5 Minute Wrapup)

Jun 16, 2017

Here's what you can expect from The 5 Minute Wrapup in the coming months and years.

More Views on News

Most Popular

My Top 7 Stocks to Profit from Sensex 100,000(The 5 Minute Wrapup)

May 16, 2019

Tanushree Banerjee explains everything you need to know about the Rebirth of India and Sensex 100,000.

3 Stocks to Bet on to Become a 'Dividend Millionaire'(Profit Hunter)

May 14, 2019

As markets continue to rattle amid earning season, upcoming elections, volatile crude price and US China trade war, it's a great idea to add some stability to your portfolio by adding dividend stocks.

Indian Steel: The Perfect Multibagger Opportunity(Profit Hunter)

May 17, 2019

A structurally strong Indian Steel Industry will help India achieve 8%+ GDP growth in the coming years.

What Makes TVS Srichakra and CCL Products a Cut Above the Rest?(The 5 Minute Wrapup)

May 17, 2019

Despite the commodity nature of their businesses, these two stocks have rewarded shareholders well.

The Bitter Pill that Will Lay the Foundation for Sensex 100,000(The 5 Minute Wrapup)

May 14, 2019

These companies will help the Sensex more than double from current levels.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2019
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

ABBOTT INDIA SHARE PRICE


May 24, 2019 (Close)

TRACK ABBOTT INDIA

  • Track your investment in ABBOTT INDIA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

ABBOTT INDIA 5-YR ANALYSIS

COMPARE ABBOTT INDIA WITH

MARKET STATS